Menu
Back to Journals » Infection and Drug Resistance » Volume 14
Genetic Variation in Metronidazole Metabolism and Oxidative Stress Pathways in Clinical Giardia lamblia Assemblage A and B Isolates [Corrigendum]
Authors Saghaug CS , Klotz C, Kallio JP , Brattbakk HR, Stokowy T , Aebischer T , Kursula I , Langeland N , Hanevik K
Received 10 September 2021
Accepted for publication 10 September 2021
Published 14 September 2021 Volume 2021:14 Pages 3727—3728
Saghaug CS, Klotz C, Kallio JP, et al. Infect Drug Resist. 2019;12:1221–1235.
The authors have advised NR-1 was used throughout the paper to denote the gene named in GiardiaDB as “Nitroreductase family protein fused to ferredoxin domain Fd-NR1” (DHA2_153380/GSB_153178), while in recent literature this is often denoted NR2/GlNR2. Likewise, NR-2 was used to denote the gene named in GiardiaDB as “Nitroreductase Fd-NR-2” (DHA2_22677/GSB_22677), while in recent literature this is often denoted NR1/GlNR1.
The authors acknowledge that using the NR gene names as annotated in GiardiaDB may cause confusion and therefore, bring this to the attention of readers that more correctly what is named “NR-1” in the paper should be read as “NR-2”, and “NR-1” should be read as “NR-2”.
The authors apologize for not having considered this issue in the original manuscript.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.